BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17509106)

  • 41. Severe vasospastic angina with hemodynamic compromise related to the infusion of dimethyl sulfoxide (DMSO)-cryopreserved autologous peripheral blood stem cells.
    Bambace NM; Lachance S
    Ann Hematol; 2013 Nov; 92(11):1571-2. PubMed ID: 23580150
    [No Abstract]   [Full Text] [Related]  

  • 42. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM.
    Lioznov M; Dellbrügger C; Sputtek A; Fehse B; Kröger N; Zander AR
    Bone Marrow Transplant; 2008 Jul; 42(2):121-8. PubMed ID: 18391988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.
    Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC
    J Clin Oncol; 2009 Mar; 27(8):1243-9. PubMed ID: 19164207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan.
    Ferrara F; Palmieri S; Pedata M; Viola A; Izzo T; Criscuolo C; Mele G
    Hematol Oncol; 2009 Mar; 27(1):40-5. PubMed ID: 19206083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation.
    Chen-Plotkin AS; Vossel KA; Samuels MA; Chen MH
    Neurology; 2007 Mar; 68(11):859-61. PubMed ID: 17353475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral blood progenitor uncontrolled-rate freezing: a single pediatric center experience.
    Iannalfi A; Bambi F; Tintori V; Lacitignola L; Bernini G; Mariani MP; Sanvito MC; Pagliai F; Brandigi F; Muscarella E; Tapinassi F; Faulkner L
    Transfusion; 2007 Dec; 47(12):2202-6. PubMed ID: 17714421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation.
    Iqbal T; Rajagopal T; Halpenny M; Yang L; Martin L; Giulivi A; McDiarmid S; Huebsch L; Allan DS
    Exp Hematol; 2008 Apr; 36(4):506-12. PubMed ID: 18261841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Isolation, culture and cryopreservation of cells derived from fetal appendages].
    Yu XM; Xue ZG; Dai GS; Xu X; Chen WA; Fan KW; Liang DS; Xia JH
    Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):447-50. PubMed ID: 18457259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood.
    Rodrigues JP; Paraguassú-Braga FH; Carvalho L; Abdelhay E; Bouzas LF; Porto LC
    Cryobiology; 2008 Apr; 56(2):144-51. PubMed ID: 18313656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
    Ikeda K; Minakawa K; Yamahara K; Yamada-Fujiwara M; Okuyama Y; Fujiwara SI; Yamazaki R; Kanamori H; Iseki T; Nagamura-Inoue T; Kameda K; Nagai K; Fujii N; Ashida T; Hirose A; Takahashi T; Ohto H; Ueda K; Tanosaki R
    Transfusion; 2022 Jun; 62(6):1280-1288. PubMed ID: 35396716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells.
    Higman MA; Port JD; Beauchamp NJ; Chen AR
    Bone Marrow Transplant; 2000 Oct; 26(7):797-800. PubMed ID: 11042664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia.
    Gimsing P; Hansen M; Knudsen LM; Knoblauch P; Christensen IJ; Ooi CE; Buhl-Jensen P
    Eur J Haematol; 2008 Sep; 81(3):170-6. PubMed ID: 18510700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation].
    Chen Y; Xu LP; Liu DH; Chen YH; Han W; Shi HX; Zhang XH; Wang JZ; Chen H; Liu KY; Huang XJ; Lu DP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):964-6. PubMed ID: 17650420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
    Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience.
    Ballova V; Ladicka M; Vranovsky A; Lakota J
    Neoplasma; 2008; 55(5):428-36. PubMed ID: 18665754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.